News

Chandra Briggman among the Virginia Best Black Business Leaders

Richmond, VA /Virginia Business/ – Black History Month traces its origins to an annual weeklong observance started in 1926 by historian and scholar Carter G. Woodson, a Virginia native. And since then, the February celebration of Black history makers and events has been intertwined with commemorating successful business icons like fellow Virginia-born greats Maggie Walker and Booker T. Washington.

With this in mind, Virginia Business presents our 2023 Virginia Black Business Leaders Awards, recognizing a reader-nominated group of some of the state’s most accomplished Black executives. On this inaugural list are 17 leaders, chosen from 108 nominated executives in finance, federal contracting, higher education, law, technology and other sectors. Our editorial team selected the 17 winners, scoring nominations based on factors including overall professional achievement, community impact and mentoring.

Chandra Briggman, President and CEO, Activation Capital, RichmondThe leader since 2020 of a Richmond-based innovation incubator that includes a biotech park, startup development and a newly invigorate

d cluster accelerator for pharmaceutical research and manufacturing, Briggman is off to a fast start. Growing up in a town of 2,000 in rural South Carolina, she was inspired by her parents to pursue innovation.

“Neither one of my parents had the opportunity to go to college,” Briggman says. “I consider them two of the smartest people I know. They were doers and experimenters, and that foundation was important.”

After college, Briggman worked for the U.S. Postal Service, where she learned about the intersection of service and technology, then for a Boston nonprofit promoting entrepreneurship. At Activation Capital, her role is “to manufacture entrepreneurs at scale,” she says — including recently landing a $53 million federal grant to expand manufacturing and development of pharmaceuticals in the Richmond region.

Read more here.

Recent News

06/25/2025

Liquet Medical Closes Oversubscribed Seed Round to Launch Pilot Study Evaluating Real-Time Hemodynamic Monitoring

Liquet Medical, a clinical-stage medical device company developing the Versus™ Catheter — a first-of-its-kind dual-tipped catheter system cleared by the FDA for controlled and selective infusion of fluids into the pulmonary vasculature and hemodynamic monitoring — announced the successful and oversubscribed close of its Seed funding round, which officially closed in May 2025. The capital

06/25/2025

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the recent execution of agreements for the production of AD04 (0.33 mg ondansetron tablets), supporting both the completion of upcoming clinical trials and the planned New Drug Application (NDA) submission to the U.S.

06/24/2025

AgroSpheres and Wilbur-Ellis Launch FUN-THYME™, a Powerful Broad-Spectrum Biofungicide Built on Novel AgriCell® Technology

AgroSpheres, a biotechnology company transforming crop protection with biobased innovations, today announced the commercial launch of FUN-THYME™, a groundbreaking, broad-spectrum biofungicide derived from thyme oil and delivered through the company’s proprietary AgriCell encapsulation platform. Through an exclusive distribution agreement, Wilbur-Ellis will introduce FUN-THYME™ to growers across the United States, helping them protect high-value crops including